Koob George F
Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla California, USA.
Drug Discov Today Dis Models. 2008 Winter;5(4):207-215. doi: 10.1016/j.ddmod.2009.04.002.
Drug addiction can be defined by a compulsion to seek and take drug and loss of control in limiting intake, and the excessive drug taking derives from multiple motivational mechanisms. One such mechanism is the emergence of a negative emotional state when access to the drug is prevented, reflecting hedonic homeostatic dysregulation. Excessive drug taking then results in part via the construct of negative reinforcement. The negative emotional state that drives such negative reinforcement is hypothesized to derive from dysregulation of key neurochemical elements involved in reward and stress within basal forebrain structures, including the ventral striatum and extended amygdala. Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in dopamine and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as corticotropin-releasing factor (CRF), in the extended amygdala. Chronic exposure or extended access to self-administration of all major drugs of abuse produces during abstinence increases in reward thresholds, increases in aversive anxiety-like responses, increases in extracellular levels of CRF in the central nucleus of the amygdala, and increases in drug self-administration. CRF receptor antagonists block excessive drug intake produced by dependence. A combination of decreased reward system function and increased brain stress response system function is hypothesized to be responsible for hedonic homeostatic dysregulation that drives drug seeking behavior in dependence. Such hedonic dysregulation is hypothesized to extend into protracted abstinence to provide a residual negative emotional state that enhances the salience of cues eliciting drug seeking and relapse.
药物成瘾可定义为一种寻求和服用药物的强迫行为以及在限制摄入量方面失去控制,而过度用药源于多种动机机制。其中一种机制是在被阻止获取药物时出现负面情绪状态,这反映了享乐稳态失调。然后,过度用药部分是通过负强化机制导致的。驱动这种负强化的负面情绪状态被认为源于基底前脑结构(包括腹侧纹状体和扩展杏仁核)中参与奖赏和应激的关键神经化学元素的失调。这些结构中的特定神经化学元素不仅包括奖赏神经传递的减少,如腹侧纹状体中多巴胺和阿片肽功能的降低,还包括大脑应激系统的激活,如扩展杏仁核中的促肾上腺皮质激素释放因子(CRF)。长期接触或延长所有主要滥用药物的自我给药时间,在戒断期间会导致奖赏阈值升高、厌恶焦虑样反应增加、杏仁核中央核中CRF的细胞外水平升高以及药物自我给药增加。CRF受体拮抗剂可阻断由依赖引起的过度药物摄入。奖赏系统功能降低和大脑应激反应系统功能增加的组合被认为是导致享乐稳态失调的原因,这种失调驱动了依赖状态下的药物寻求行为。这种享乐失调被认为会持续到长期戒断,以提供一种残留的负面情绪状态,增强引发药物寻求和复发的线索的显著性。